{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:52:38Z","timestamp":1773928358029,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00247","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T04:13:23Z","timestamp":1588047203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhibitory Effects of Fosmidomycin Against Babesia microti in vitro"],"prefix":"10.3389","volume":"8","author":[{"given":"Sen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangsiqi","family":"Ao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19974","DOI":"10.1074\/jbc.AC118.005771","article-title":"Establishment of a continuous in vitro culture of Babesia duncani in human erythrocytes reveals unusually high tolerance to recommended therapies.","volume":"293","author":"Abraham","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1021\/jm2000085","article-title":"Design, synthesis, and X-ray crystallographic studies of alpha-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.","volume":"54","author":"Andaloussi","year":"2011","journal-title":"J. Med. Chem."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019334","article-title":"Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.","volume":"6","author":"Baumeister","year":"2011","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","article-title":"The SWISS-MODEL repository-new features and functionality.","volume":"45","author":"Bienert","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1128\/aac.00392-396","article-title":"Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.","volume":"50","author":"Borrmann","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1371\/journal.ppat.0030148","article-title":"Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa.","volume":"3","author":"Brayton","year":"2007","journal-title":"PLoS Pathog."},{"key":"B7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.molbiopara.2011.10.009","article-title":"Characterization of acyl carrier protein and LytB in Babesia bovis apicoplast.","volume":"181","author":"Caballero","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"51749","DOI":"10.1074\/jbc.M408360200","article-title":"The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum.","volume":"279","author":"Cassera","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA reductase inhibitors.","volume":"33","author":"Endo","year":"1992","journal-title":"J. Lipid Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nchembio.2007.5","article-title":"The function of terpene natural products in the natural world.","volume":"3","author":"Gershenzon","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1021\/acsinfecdis.7b00159","article-title":"biological studies and target engagement of the 2- C-Methyl-d-Erythritol 4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent (1 R,3 S)-MMV008138 and analogs.","volume":"4","author":"Ghavami","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1645\/ge-3149rn","article-title":"Enzootic Babesia microti in Maine.","volume":"89","author":"Goethert","year":"2003","journal-title":"J. Parasitol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective.","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-018-3038-3037","article-title":"The MEP pathway in Babesia orientalis apicoplast, a potential target for anti-babesiosis drug development.","volume":"11","author":"He","year":"2018","journal-title":"Parasit Vectors"},{"key":"B15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7326\/0003-4819-155-8-201110180-201110362","article-title":"Transfusion-associated babesiosis in the United States: a description of cases.","volume":"155","author":"Herwaldt","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10096-007-0333-331","article-title":"First confirmed autochthonous case of human Babesia microti infection in Europe.","volume":"26","author":"Hildebrandt","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/ec.00073-12","article-title":"Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum.","volume":"12","author":"Howe","year":"2013","journal-title":"Eukaryot Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40588-014-0006-7","article-title":"Isoprenoid metabolism in apicomplexan parasites.","volume":"1","author":"Imlay","year":"2014","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","article-title":"Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.","volume":"285","author":"Jomaa","year":"1999","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1021\/bi0118207","article-title":"E. coli MEP synthase: steady-state kinetic analysis and substrate binding.","volume":"41","author":"Koppisch","year":"2002","journal-title":"Biochemistry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1056\/nejm200011163432004","article-title":"Atovaquone and azithromycin for the treatment of babesiosis.","volume":"343","author":"Krause","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets.","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1084\/jem.20151519","article-title":"Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.","volume":"213","author":"Lawres","year":"2016","journal-title":"J. Exp. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/0035-9203(83)90129-90123","article-title":"Effects of qinghaosu and related compounds on incorporation of [G-3H] hypoxanthine by Plasmodium falciparum in vitro.","volume":"77","author":"Li","year":"1983","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jmb.2004.10.030","article-title":"The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.","volume":"345","author":"Mac Sweeney","year":"2005","journal-title":"J. Mol. Biol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/381482a0","article-title":"Plastid in human parasites.","volume":"381","author":"McFadden","year":"1996","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-70","article-title":"Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria.","volume":"6","author":"Na-Bangchang","year":"2007","journal-title":"Malar. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1084\/jem.20110039","article-title":"Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii.","volume":"208","author":"Nair","year":"2011","journal-title":"J. Exp. Med."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002323","article-title":"Five questions about non-mevalonate isoprenoid biosynthesis.","volume":"7","author":"Odom","year":"2011","journal-title":"PLoS Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molbiopara.2009.12.001","article-title":"Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene.","volume":"170","author":"Odom","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/clpt.2009.51","article-title":"The global portfolio of new antimalarial medicines under development.","volume":"85","author":"Olliaro","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrmicro843","article-title":"Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast.","volume":"2","author":"Ralph","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0002-9343(84)90298-5","article-title":"Babesiosis in splenectomized adults. Review of 22 reported cases.","volume":"76","author":"Rosner","year":"1984","journal-title":"Am. J. Med."},{"key":"B34","first-page":"489","article-title":"Human babesiosis.","volume":"69","author":"Rozej-Bielicka","year":"2015","journal-title":"Przegl. Epidemiol."},{"key":"B35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00219605","article-title":"An electron microscopic study of Babesia microti invading erythrocytes.","volume":"169","author":"Rudzinska","year":"1976","journal-title":"Cell Tissue Res."},{"key":"B36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2307\/3280290","article-title":"Susceptibility of five strains of mice to Babesia microti of human origin.","volume":"65","author":"Ruebush","year":"1979","journal-title":"J. Parasitol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"14081","DOI":"10.1073\/pnas.1001962107","article-title":"A new family of enzymes catalyzing the first committed step of the methylerythritol 4-phosphate (MEP) pathway for isoprenoid biosynthesis in bacteria.","volume":"107","author":"Sangari","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/srep35284","article-title":"Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions.","volume":"6","author":"Silva","year":"2016","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/cid\/cix477","article-title":"Clinical and molecular evidence of atovaquone and azithromycin resistance in relapsed Babesia microti infection associated with rituximab and chronic lymphocytic leukemia.","volume":"65","author":"Simon","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B40","first-page":"71","article-title":"In vitro inhibitory effect of fosmidomycin on the asexual growth of Babesia bovis and Babesia bigemina.","volume":"18","author":"Sivakumar","year":"2008","journal-title":"J. Protozool. Res."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/srep00009","article-title":"Molecular basis of fosmidomycin\u2019s action on the human malaria parasite Plasmodium falciparum.","volume":"1","author":"Umeda","year":"2011","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes.","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/s0006-3495(02)75210-75217","article-title":"Extreme pathway analysis of human red blood cell metabolism.","volume":"83","author":"Wiback","year":"2002","journal-title":"Biophys. J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1086\/649859","article-title":"Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.","volume":"50","author":"Wormser","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijppaw.2012.11.003","article-title":"Natural history of Zoonotic Babesia: role of wildlife reservoirs.","volume":"2","author":"Yabsley","year":"2013","journal-title":"Int. J. Parasitol. Parasites Wildl."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum.","volume":"9","author":"Yeh","year":"2011","journal-title":"PLoS Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1537-2995.2012.03612.x","article-title":"Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program.","volume":"52","author":"Young","year":"2012","journal-title":"Transfusion"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1021\/bi200113y","article-title":"A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.","volume":"50","author":"Zhang","year":"2011","journal-title":"Biochemistry"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00247\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T10:24:23Z","timestamp":1615458263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00247\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":48,"alternative-id":["10.3389\/fcell.2020.00247"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00247","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"article-number":"247"}}